Ident. | Authors (with country if any) | Title |
---|
000E20 |
Patrick A. Oberholzer [États-Unis] ; Damien Kee [États-Unis, Australie] ; Piotr Dziunycz [Suisse] ; Antje Sucker [Allemagne] ; Nyam Kamsukom [France] ; Robert Jones [États-Unis] ; Christine Roden [États-Unis] ; Clinton J. Chalk [États-Unis] ; Kristin Ardlie [États-Unis] ; Emanuele Palescandolo [États-Unis] ; Adriano Piris [États-Unis] ; Laura E. Macconaill [États-Unis] ; Caroline Robert [France] ; Günther F. L. Hofbauer [Suisse] ; Grant A. Mcarthur [États-Unis] ; Dirk Schadendorf [Allemagne] ; Levi A. Garraway [États-Unis] | RAS Mutations Are Associated With the Development of Cutaneous Squamous Cell Tumors in Patients Treated With RAF Inhibitors |
001F10 |
Laetitia Aymeric [France] ; Lionel Apetoh [France] ; François Ghiringhelli [France] ; Antoine Tesniere [France] ; Isabelle Martins [France] ; Guido Kroemer [France] ; Mark J. Smyth [Australie] ; Laurence Zitvogel [France] | Tumor Cell Death and ATP Release Prime Dendritic Cells and Efficient Anticancer Immunity |
002429 |
Arnaud Bonnomet [Belgique, France] ; Anne Brysse [Belgique] ; Anthony Tachsidis [Australie] ; Mark Waltham [Australie] ; Erik W. Thompson [Australie] ; Myriam Polette [France] ; Christine Gilles [Belgique] | Epithelial-to-Mesenchymal Transitions and Circulating Tumor Cells |
003076 |
Aude Echalier [Royaume-Uni, France] ; Karima Bettayeb [France] ; Yoan Ferandin [France] ; Olivier Lozach [France] ; Monique Clement [France] ; Annie Valette [France] ; Francois Liger [France] ; Bernard Marquet [France] ; Jonathan C. Morris [Australie] ; Jane A. Endicott [Royaume-Uni] ; Benoit Joseph [France] ; Laurent Meijer [France] | Meriolins (3-(Pyrimidin-4-yl)-7-azaindoles) : Synthesis, Kinase Inhibitory Activity, Cellular Effects, and Structure of a CDK2/Cyclin A/Meriolin Complex |
003405 |
K. A. Benhadji [France] ; M. Serova [France] ; A. Ghoul [France] ; E. Cvitkovic [France] ; C. Le Tourneau [France] ; S. M. Ogbourne [Australie] ; F. Lokiec [France] ; F. Calvo [France] ; P. Hammel [France] ; S. Faivre [France] ; E. Raymond [France] | Antiproliferative activity of PEP005, a novel ingenol angelate that modulates PKC functions, alone and in combination with cytotoxic agents in human colon cancer cells |
003C47 |
Sylvie Mavel [France] ; Branko Dikic [Australie] ; Somchit Palakas [France] ; Patrick Emond [France] ; Ivan Greguric [Australie] ; Adrienne Gomez De Gracia [France] ; Filomena Mattner [Australie] ; Manuel Garrigos [France] ; Denis Guilloteau [France] ; Andrew Katsifis [Australie] | Synthesis and biological evaluation of a series of flavone derivatives as potential radioligands for imaging the multidrug resistance-associated protein 1 (ABCC1/MRP1) |
004297 |
Simon P. B. Ovenden [Australie, France] ; JIN YU ; Jill Bernays ; SOO SAN WAN ; Larissa J. Christophidis ; Gian Sberna ; R. Murray Tait ; Howard G. Wildman ; Dominique Lebeller ; Denis Platel ; Tom W. May [Australie] ; Barbara M. Meurer-Grimes | Trichomycins A and B : Antibacterial triterpenes from the new species Tricholoma sp. AU1 |
004334 |
Kirilee A. Wilson [Australie] ; Séverine B R [France] ; Anne L. Maerz [Australie] ; Marc Alizon [France] ; Pantelis Poumbourios [Australie] | The conserved glycine-rich segment linking the N-terminal fusion peptide to the coiled coil of human T-cell leukemia virus type 1 transmembrane glycoprotein gp21 is a determinant of membrane fusion function |
004D37 |
Jason S. Carroll [Australie] ; Danielle K. Lynch [Australie] ; Alexander Swarbrick [Australie] ; Jack-Michel Renoir [France] ; Boris Sarcevic [Australie] ; Roger J. Daly [Australie] ; Elizabeth A. Musgrove [Australie] ; Robert L. Sutherland [Australie] | p27Kip1 induces quiescence and growth factor insensitivity in tamoxifen-treated breast cancer cells |
005365 |
D. R. Richardson [Australie] | Iron chelators as therapeutic agents for the treatment of cancer |
005793 |
Chantal Etievant [France] ; Anna Kruczynski [France] ; Jean-Marc Barret [France] ; Alexandra S. Tait [Australie] ; Maria Kavallaris [Australie] ; Bridget T. Hill [France] | Markedly diminished drug resistance-inducing properties of vinflunine (20', 20'-difluoro-3', 4'-dihydrovinorelbine) relative to vinorelbine, identified in murine and human tumour cells in vivo and in vitro |
005873 |
Kaori Koyama [Australie] ; Kathy Myles [Australie] ; Robin Smith [Australie] ; Zygmunt Krozowski [Australie] | Expression of the 11 β-hydroxysteroid dehydrogenase type II enzyme in breast tumors and modulation of activity and cell growth in PMC42 cells |
005901 |
Teresa Mancilla [Mexique] ; Lourdes Carrillo [Mexique] ; Luis S. Zamudio Rivera [Mexique] ; Carlos Camacho Camacho [Belgique] ; Dick De Vos [Pays-Bas] ; Robert Kiss [Belgique] ; Francis Darro [France] ; Bernard Mahieu [Belgique] ; Edward R. T. Tiekink [Australie] ; Hubert Rahier [Belgique] ; Marcel Gielen [Belgique] ; Martine Kemmer [Belgique] ; Monique Biesemans [Belgique] ; Rudolph Willem [Belgique] | Di-n-butyltin(iv) derivatives of bis(carboxymethyl)benzylamines : synthesis, NMR and X-ray structure characterization and in vitro antitumour properties |
006043 |
A. Duval [France] ; J. Gayet [France] ; X.-P. Zhou [France] ; B. Iacopetta [Australie] ; G. Thomas [France] ; R. Hamelin [France] | Frequent frameshift mutations of the TCF-4 gene in colorectal cancers with microsatellite instability |
006336 |
R. Khanna [Australie] ; P. Busson [France] ; S. R. Burrows [Australie] ; C. Raffoux [France] ; D. J. Moss [Australie] ; J. M. Nicholls [Hong Kong] ; L. Cooper [Australie] | Molecular characterization of antigen-processing function in nasopharyngeal carcinoma (NPC): Evidence for efficient presentation of Epstein-Barr virus cytotoxic T-cell epitopes by NPC cells |
006791 |
D. Decaudin [France] ; S. Geley [Australie] ; T. Hirsch [France] ; M. Castedo [France] ; P. Marchetti [France] ; A. Macho [France] ; R. Kofler [Australie] ; G. Kroemer [France] | Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents |